相关实验视频

Updated: Jun 12, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

一个全基因组排列的CRISPR屏幕识别了PLSCR1作为SARS-CoV-2进入的内在障碍,最近的病毒变体已经进化到抵抗病毒变体

Jérémie Le Pen¹, Gabrielle Paniccia¹, Volker Kinast^2,3

¹Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, United States of America.

|September 24, 2024

概括

干扰子 (IFN) 是宿主病毒相互作用的关键. 这项研究确定了PLSCR1作为一种限制SARS-CoV-2进入的基因,独立于IFN信号传输,并探索了它在COVID-19严重性中的作用.

科学领域:

病毒学病毒学
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

干扰子 (IFN) 是宿主病毒相互作用的关键调节者.
了解影响严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 感染的宿主因素对于对抗冠状病毒疾病2019 (COVID-19) 至关重要.

研究的目的:

用全基因组的CRISPR选器识别影响SARS-CoV-2感染的人类基因,有或没有IFN.
将功能屏幕数据与COVID-19患者的人类遗传研究相结合.
描述已识别的基因,特别是PLSCR1在SARS-CoV-2限制中的作用.

主要方法:

在IFN.的存在和缺席下全基因组排列的CRISPR淘汰屏幕.
来自67项大规模研究的SARS-CoV-2相互作用基因的综合分析.
PLSCR1的功能性特征,包括其与TMPRSS2的相互作用和对SARS-CoV-2变种的反应.

主要成果:

在COVID-19患者遗传学和细胞培养屏幕中确定了28个高度相关的基因,其中许多与IFN通路有关.
发现PLSCR1限制了SARS-CoV-2的进入,独立于IFN的诱导和信号传递.
具体来说,PLSCR1抑制了尖端介导的病毒进入,主要是通过内细胞路线,而TMPRSS2.2克服了这一限制.
最近的SARS-CoV-2变种已经发展出了逃避PLSCR1-介导限制的机制.
研究了人类PLSCR1变异的功能影响及其与严重COVID-19的关联.

结论:

PLSCR1是SARS-CoV-2进入的关键宿主限制因子,独立于IFN信号传输运作.
TMPRSS2可以克服PLSCR1介导的限制,突出显示病毒进入途径的重要性.
SARS-CoV-2 变种已经开发出规避 PLSCR1 的策略,这表明正在进行的进化军备竞赛.
PLSCR1遗传变异可能导致COVID-19的严重程度,需要进一步调查.

更多相关视频

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...